Blog
RSS FeedPosted by Michael Wonder on 10 Jul 2019
A Supreme Court ruling may have made it harder to get some info from the FDA
9 July 2019 - Anyone seeking certain information about a medicine from the FDA may have a harder time getting ...
Posted by Michael Wonder on 26 Jun 2019
FDA seeks public feedback on new drug approval transparency efforts
26 June 2019 - Today the U.S. FDA issued a Federal Register notice, New Drugs Regulatory Program Modernization: Improving Approval Package ...
Posted by Michael Wonder on 18 Jun 2019
Statement on a new effort to improve transparency and predictability for generic drug applicants to help increase timely access to high-quality, lower cost generic drugs
18 June 2019 - The U.S. FDA is committed to helping facilitate American patients’ access to lower-cost generic medicines by ...
Posted by Michael Wonder on 11 Jun 2019
Should the FDA disclose new filings for drugs, biologics and biosimilars?
11 June 2019 - In 2010, the FDA issued draft recommendations on increasing the transparency of the FDA’s processes and ...
Posted by Michael Wonder on 04 Jun 2019
Hiding in plain sight: the FDA’s approach to disclosing new drug applications is a disservice to public health
4 June 2019 - Remember in high school when a friend told you a secret and you guarded it assiduously, ...
Posted by Michael Wonder on 04 Jun 2019
Public disclosure of the filing of new drug and therapeutic biologics applications with the US Food and Drug Administration
3 June 2019 - Current regulations prohibit the US FDA from publicly disclosing the existence of pending new drug applications or ...
Posted by Michael Wonder on 15 May 2019
Drug prices in TV ads: how transparent are they?
15 May 2019 - A website launched by pharmaceutical giant Eli Lilly earlier this year leads with a daunting statement ...
Posted by Michael Wonder on 13 May 2019
Grandstanding, not real change: why drug prices in TV ads will be confusing and irrelevant
13 May 2019 - In a fit of hubris, President Trump believes he is making drug makers “come clean” by ...
Posted by Michael Wonder on 28 Mar 2019
Why J&J raced to put drug prices in some TV ads
28 March 2019 - One notion proposed by the Trump administration to blunt the rising cost of medicines is to ...
Posted by Michael Wonder on 24 Mar 2019
Drug prices on TV? They may be coming.
23 March 2019 - The Trump administration is moving ahead with its proposal to require drug companies to disclose the ...
Posted by Michael Wonder on 15 Nov 2018
Disclosing prescription-drug prices in advertisements — legal and public health issues
14 November 2018 - On October 15, 2018, the CMS proposed a rule requiring television advertisements for prescription drugs and ...
Posted by Michael Wonder on 12 Nov 2018
Drug prices on ads: as ‘relevant’ as percent daily value on food labels
9 November 2018 - President Trump announced late last month that his administration will push back on high drug costs ...
Posted by Michael Wonder on 25 Oct 2018
Pharmaceutical industry challenges Trump plan forcing companies to reveal drug prices in TV ads
25 October 2018 - Symbicort, an inhaler marketed to people whose lung disease makes them “huff and puff,” rolls off ...
Posted by Michael Wonder on 22 Oct 2018
Trump and his team fight for health consumers, starting with drug price transparency
22 October 2018 - Drugs like EpiPen have exorbitant prices due to price gouging. The Trump administration is taking steps to ...
Posted by Michael Wonder on 16 Oct 2018
Drug price transparency won’t end the patent games
17 October 2018 - Just look at Humira, which is keeping its U.S. monopoly as generics hit the European market. ...